• Gallus, A.S., Hirsh, J. & Gent, M. (1973) Relevance of preoperative blood tests to postoperative leg-vein thrombosis. The Lancet, 2, 805809.
  • Kalbfleish, J.D. & Prentice, R.L. (1980) The Statistical Analysis of Failure Time Data. John Wiley and Sons, New York.
  • Korte, W., Clarke, S. & Lefkowitz, J.B. (2000) Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism. American Journal of Clinical Pathology, 113, 123127.
  • Koster, T., Blann, A.D., Briet, E., Vandenbroucke, J.P. & Rosendaal, F.R. (1995) Role of clotting factor VIII in effect of von willebrand factor on occurrence of deep-vein thrombosis. The Lancet, 345, 152155.
  • Kraaijenhagen, R.A., Anker, P.S.I., Koopman, M.M.W., Reitsma, P.H., Prins, M.H., Van Den Ende, A. & Buller, H.R. (2000) High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thrombosis and Haemostasis, 83, 59.
  • Kyrle, P.A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K. & Eichinger, S. (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. New England Journal of Medicine, 343, 457462.
  • Legnani, C., Cosmi, B., Cini, M., Frascaro, M., Guazzaloca, G. & Palareti, G. (2004) High plasma levels of factor VIII and risk of recurrence of venous thromboembolism. British Journal of Haematology, 124, 504510.
  • Marlar, R.A., Bauer, P.J., Endres-Brooks, J.L., Montgomery, R.R., Miller, C.M. & Schanen, M.M. (1984) Comparison of sensitivity of commercial APTT reagents in the detection of mild coagulopathies. American Journal of Clinical Pathology, 82, 436439.
  • McKenna, R., Bachmann, F. & Miro-Quesada, M. (1977) Thrombo-embolism in patients with abnormally short activated partial thromboplastin time. Thrombosis and Haemostasis, 38, 893899.
  • Meijers, J.C.M., Tekelenburg, W.L.H., Bouma, B.N., Bertina, R.M. & Rosendaal, F.R. (2000) High levels of coagulation factor XI as a risk factor for venous thrombosis. New England Journal of Medicine, 342, 696701.
  • O'Donnell, J., Tuddenham, E.G.D., Manning, R., Kemballcook, G., Johnson, D. & Laffan, M. (1997) High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thrombosis and Haemostasis, 77, 825828.
  • Pilgeram, L.O. (1974) Abnormalities in clotting and thrombolysis as a risk factor for stroke. Thrombosis et Diathesis Haemorrhagica, 31, 245264.
  • Reddy, N.M., Hall, S.W. & MacKintosh, F.R. (1999) Partial thromboplastin time – prediction of adverse events and poor prognosis by low abnormal values. Archives of Internal Medicine, 159, 27062710.
  • Ten Boekel, E. & Bartels, P. (2002) Abnormally short activated partial thromboplastin times are related to elevated plasma levels of TAT, F1+2, d-dimer and FVIII:C. Pathophysiology of Haemostasis and Thrombosis, 32, 137142.
  • Tripodi, A., Chantarangkul, V., Martinelli, I., Bucciarelli, P. & Mannucci, P.M. (2004) A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood, 104, 36313634.
  • Turi, D.C. & Peerschke, E.L. (1986) Sensitivity of three activated partial thromboplastin time reagents to coagulation factor deficiencies. American Journal of Clinical Pathology, 85, 4349.
  • Vlieg, A.V., VanderLinden, I.K., Bertina, R.M. & Rosendaal F.R. (2000) High levels of factor IX increase the risk of venous thrombosis. Blood, 95, 36783682.
  • Weltermann, A., Eichinger, S., Bialonczyk, C., Minar, E., Hirschl, M., Quehenberger, P., Schonauer, V. & Kyrle, P.A. (2003) The risk of recurrent venous thromboembolism among patients with high factor IX levels. Journal of Thrombosis and Haemostasis, 1, 2832.
  • White, G.C. (2003) The partial thromboplastin time: defining an era in coagulation. Journal of Thrombosis and Haemostasis, 1, 22672270.